Updated May. 16, 2013 at 5:35 a.m.

Premium Lock New drug model? Quintiles to develop compounds with Merck Serono

Published: 2013-05-15 13:09:00
Updated: 2013-05-16 05:35:47

Drug deal Drug deal

Fresh off an IPO that produced $1 billion for investors and the company, Quintiles on Wednesday announced a drug development deal in which it will work with Germany-based Merck Serono. But this contract is much different from others in which Quintiles shared some of the financial risk for new drug development. WRALTechWire Insiders get the story beyond the press release....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll